| Article

“Leaders in pain medicine recognize that terminology needs to keep up with our understanding of disorders, their pathophysiologies, and their treatment.” So say the authors of an article published in the Journal of Pain Research, one of whom is long time PAINWeek faculty, Michael Schatman, PhD, CPE...

| Article

At least 1 in 5 Australians live with chronic pain. Much like North America, that pain translates into high health costs and low productivity. $4.1 million will help to improve access to rural and remote Australians and those who most need chronic long term pain management. Among other benefits, the...

| Article

The European Journal of Pain published a 2-part clinical practice guideline: part 1 covers the role of opioids in the management of chronic noncancer pain (CNCP) and part 2, special situations. The position paper was commissioned by the European Pain Federation (EFIC). Eight scientific societies and...

| Article

Insurance companies would be more likely to pay for nontraditional approaches to pain management if they knew these methods worked. Jon Porter, medical director of the University of Vermont Medical Center Comprehensive Pain Program, and researchers compiled qualitative data from people who...

| Article

Does money talk? How can hospitals be encouraged to promote quicker treatment for opioid use disorder? Researchers at Perelman School of Medicine at the University of Pennsylvania published findings in the journal of Psychiatric Services, their objectives being, “a voluntary financial incentive...

| Article

An Annals of Internal Medicine online article seeks “To characterize the quality of safety and efficacy data in new drug applications (NDAs) for opioid analgesics approved by the FDA between 1997 and 2018.” Researchers state that “Approvals of prescription opioids by the U.S. Food and Drug...

| Article

A poster abstract (LB008) presented at the American Academy of Pain Medicine 36th Annual Meeting acknowledges the potential of sweat as a biofluid alternative for drug testing. The abstract states that, although used extensively, “sampling of urine is inconvenient, tamper prone, and results are...

| Article

From the European Journal of Medicinal Chemistry

Highlights:

• We describe a novel class of diethylaminocarbonyl-2-benzenesulfamide analogs to acetaminophen/paracetamol.

• Compounds, 3b and 3r, lack the hepatotoxicity present in acetaminophen/paracetamol.

• 3b and 3r maintain analgesia...

| Article

Newswise — A new study led by University of Kentucky researcher April Young and Emory University researcher Hannah Cooper shows that a number of pharmacies in the Appalachian region of Kentucky are limiting the dispensing of buprenorphine, a medication used to treat opioid use disorder (OUD). This...

| Article

Michael C. Barnes, JD, MIEP, a Washington, DC, attorney on the future of pain management and drug policy. Does medical marijuana have a role?

It’s an interesting time in United States for drug policies:

  • As we see efforts to loosen restrictions on what are currently federally illicit substances...

Subscribe to drug policy

Sign-Up